Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.56 |
| ▸ | MDM4 | O15151 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | CASP3 | P42574 | 2/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29990051 | 1.00 | PTPN1 (0.56) | PTPN1MDM4TP53CASP3MDM2 | |
| SCHEMBL29700028 | 1.00 | PTPN1 (0.56) | PTPN1MDM4TP53CASP3MDM2 | |
| SCHEMBL10630934 | 0.96 | PTPN1 (0.53) | PTPN1MDM4TP53CASP3MDM2 | |
| SCHEMBL15006479 | 0.96 | PTPN1 (0.53) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL1002861 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL29714950 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL29376158 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL29351703 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL29385681 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 | |
| N- (9-Fluorenylmethoxycarbonyl)-L-Leucine SCHEMBL120560 | 0.95 | MDM4 (0.58) | PTPN1MDM4TP53CASP3MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117024528-B | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117024528-A | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-119823233-A | Synthesis method of Ruitalutide and Ruitalutide | 杭州思诺达医药科技有限责任公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119798119-A | Industrial preparation method of single-protection amino acid | 四川什邡市三高生化实业有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119708197-A | Ruitalu Process for producing peptide | 深圳翰宇药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-117024528-B | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117024528-A | Preparation method of Retatrutide | 杭州信海医药科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-113655131-B | Fmoc-Ile-OH related substance detection method | 吉尔多肽生物制药(大连市)有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116023467-A | Solid-phase synthesis method of abamectin | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-110563802-B | Group of antibacterial peptide analogues containing N-methylated amino acid and N-terminal fatty acid modification, and synthetic method and application thereof | 倪京满 | 2023-04-07 | — | — | CN | disclosed |
| CN-115541731-A | Analysis method for protecting enantiomer of amino acid | 南京锐志生物医药有限公司 | 2022-12-30 | — | — | CN | disclosed |